BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16376504)

  • 1. Small cell carcinoma of the larynx treated with irinotecan and cisplatin.
    Sone M; Uchida I; Tominaga M; Sugiura S; Nagasaka T; Nakashima T
    Auris Nasus Larynx; 2006 Jun; 33(2):223-5. PubMed ID: 16376504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
    Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
    Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of topoisomerase I inhibitors in small-cell lung cancer.
    Fukuoka M
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):9-13. PubMed ID: 11497234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case report of small cell carcinoma of the esophagus successfully treated by irinotecan and cisplatin].
    Nagahama T; Ando M; Ohbu M; Ami K; Ganno H; Taira M; Ito T
    Gan To Kagaku Ryoho; 2006 Nov; 33(12):1869-71. PubMed ID: 17212131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
    Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Small-cell carcinoma of the larynx].
    Molina Ruiz Del Portal JM; Dávila A; Jiménez V; Fernández Crehuet MJ; Pérez Arcos JA; Urquiza R
    Acta Otorrinolaringol Esp; 2000 Mar; 51(2):179-82. PubMed ID: 10804124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irinotecan therapy for small-cell lung cancer.
    Sandler A
    Oncology (Williston Park); 2002 Apr; 16(4):419-25, 428, 433; discussion 433-4, 437-8. PubMed ID: 12017533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment with chemotherapy and surgery for advanced small cell carcinoma of the esophagus.
    Tobari S; Ikeda Y; Kurihara H; Takami H; Okinaga K; Kodaira S
    Hepatogastroenterology; 2004; 51(58):1027-9. PubMed ID: 15239239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor lysis syndrome after chemotherapy for colon small cell carcinoma].
    El Mesbahi O; Beaudoin A; Louvet C; De Gramont A
    Rev Med Interne; 2004 Oct; 25(10):768-9. PubMed ID: 15471607
    [No Abstract]   [Full Text] [Related]  

  • 10. Small cell carcinoma of the larynx: imaging findings.
    Kim HJ; Hwang EG
    Auris Nasus Larynx; 1997 Oct; 24(4):423-7. PubMed ID: 9352837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of esophageal small cell carcinoma with multiple liver metastases responding to chemotherapy with irinotecan plus cisplatin.
    Endo K; Kohnoe S; Toh Y; Haraguchi M; Nishiyama K; Okamura T; Baba H; Maehara Y
    J Exp Clin Cancer Res; 2005 Dec; 24(4):647-50. PubMed ID: 16471329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of a 3-week schedule of irinotecan combined with cisplatin in previously untreated extensive-stage small-cell lung cancer.
    Lee JE; Park HS; Jung SS; Kim JO; Kim SY
    Oncology; 2007; 73(1-2):76-80. PubMed ID: 18334853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent small cell carcinoma of the ovary treated with docetaxel: A case report.
    Niimi S; Kiyokawa T; Takakura S; Ochiai K; Tanaka T
    Int J Gynecol Cancer; 2006; 16(5):1944-6. PubMed ID: 17009997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auditory effects after organ preservation protocol for laryngeal/hypopharyngeal carcinomas.
    Liberman PH; Schultz C; Gomez MV; Carvalho AL; Pellizzon AC; Testa JR; Feher O; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1265-8. PubMed ID: 15545579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractionated administration of irinotecan and cisplatin for treatment of lung cancer: a phase I study.
    Ueoka H; Tabata M; Kiura K; Shibayama T; Gemba K; Segawa Y; Chikamori K; Yonei T; Hiraki S; Harada M
    Br J Cancer; 1999 Feb; 79(5-6):984-90. PubMed ID: 10070901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irinotecan (CPT-11) combined with cisplatin for small cell carcinoma of the nasal cavity.
    Hakuba N; Hyodo M; Yokoi T; Sato H
    Auris Nasus Larynx; 2006 Mar; 33(1):67-70. PubMed ID: 16168589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of small cell undifferentiated carcinoma of the esophagus successfully treated by chemoradiotherapy].
    Kitagawa H; Akimori T; Namikawa T; Okino T; Kobayashi M; Nishioka A; Hanazaki K
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1737-9. PubMed ID: 19838038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful combination chemotherapy with irinotecan hydrochloride and cisplatin for primary gastric small cell carcinoma: report of a case.
    Funahashi H; Miyai H; Wakasugi T; Ishiguro H; Matsuo Y; Kimura M; Takeyama H
    World J Surg Oncol; 2013 Oct; 11():263. PubMed ID: 24099520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Irinotecan].
    Yokoyama A
    Nihon Rinsho; 2002 May; 60 Suppl 5():339-42. PubMed ID: 12101684
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of chemotherapy in squamous cell tumors of the larynx].
    Merlano M; Benasso M; Cavallari M; Muttini MP
    Acta Otorhinolaryngol Ital; 1991; 11 Suppl 33():129-34. PubMed ID: 1718139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.